TSUNEO KANAMARU

1.6k citations
19 papers · 1.3k indexed · 1 hit paper · h-index 10
Topics
Metabolism and Genetic Disorders (5 papers)Microbial Natural Products and Biosynthesis (4 papers)Glycosylation and Glycoproteins Research (3 papers)

In The Last Decade

TSUNEO KANAMARU

18 papers receiving 1.2k citations

Hit Papers

Synthetic analogues of fumagillin that inhibit angiogenes...199020262002201419902505007501000

Peers

TSUNEO KANAMARU
Comparison fields: 5 of 92
  • Molecular Biology 865
  • Oncology 410
  • Cancer Research 398
  • Pharmacology 122
  • Immunology and Allergy 117
Replace SHOJI KISHIMOTO with:
SHOJI KISHIMOTO Japan
Tohru Masuda Japan
Gerhard Brandner Germany
Michiko Muramatsu Japan
Lynn M. Knowles United States
Naoyo Nishida Japan
Katsuhisa Kogawa Japan
N Satomi Japan
Theoni Trangas Greece
James R. Zucali United States
TSUNEO KANAMARU relative to SHOJI KISHIMOTO Japan SHOJI KISHIMOTO's profile →
Citations per field
00.5×1.7×
SHOJI KISHIMOTO · 1×
Citations per year

Countries citing papers authored by TSUNEO KANAMARU

Since Specialization
Citations

This map shows the geographic impact of TSUNEO KANAMARU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TSUNEO KANAMARU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TSUNEO KANAMARU more than expected).

Fields of papers citing papers by TSUNEO KANAMARU

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TSUNEO KANAMARU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TSUNEO KANAMARU. The network helps show where TSUNEO KANAMARU may publish in the future.

Co-authorship network of co-authors of TSUNEO KANAMARU

This figure shows the co-authorship network connecting the top 25 collaborators of TSUNEO KANAMARU. A scholar is included among the top collaborators of TSUNEO KANAMARU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TSUNEO KANAMARU. TSUNEO KANAMARU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 61
2 14
3 7
4 8
5
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthbreakdown →
1087
6 5
7 9
8 4
9 9
10 32
11 11
12 17
13 2
14 12
15 6
16 9
17 2
18 7
19 1

About TSUNEO KANAMARU

TSUNEO KANAMARU is a scholar working on Clinical Biochemistry, Pharmacology and Biotechnology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cancer Research (398 citations), Immunology and Allergy (117 citations) and Oncology (410 citations). TSUNEO KANAMARU has collaborated with scholars based in Japan, United States and Tunisia. Frequent co-authors include Takeshi Fujita, Katsuichi Sudo, SHOJI KISHIMOTO, Donald E. Ingber, Judah Folkman, Harold Brem, Hisayoshi Okazaki, Yoshio Nakao, Mayumi Tada and Masafumi Nαkαo. Their work appears in journals such as Nature, Antimicrobial Agents and Chemotherapy and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026